Prospective assessment of a nomogram for the initiation of oral anticoagulation therapy for outpatient treatment of venous thromboembolism

Pathophysiology of Haemostasis and Thrombosis

Volumn 32, Issue 3, 2002, Pages 131-133

  Kovacs, M J ^a   Anderson, D A ^b   Wells, P S ^c  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Nomogram; Venous thromboembolism; Warfarin

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; CALIBRATION; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG MONITORING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MEDICAL ASSESSMENT; NOMOGRAM; OUTPATIENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; THROMBOGENICITY; ALGORITHM; AMBULATORY CARE; CLINICAL TRIAL; DRUG ADMINISTRATION; EVALUATION; INTERNATIONAL NORMALIZED RATIO; MULTICENTER STUDY; SAFETY; TEACHING HOSPITAL; THROMBOEMBOLISM; VEIN THROMBOSIS;

ADULT; ALGORITHMS; AMBULATORY CARE; ANTICOAGULANTS; DRUG ADMINISTRATION SCHEDULE; HOSPITALS, TEACHING; HUMANS; INTERNATIONAL NORMALIZED RATIO; PROSPECTIVE STUDIES; SAFETY; THROMBOEMBOLISM; VENOUS THROMBOSIS; WARFARIN;

EID: 0036582137     PISSN: 14248832     EISSN: None     Source Type: Journal    
DOI: 10.1159/000065215     Document Type: Article

References (10)

1. Weinmann EE, Salzman EW: Deep-vein thrombosis. N Engl J Med 1994;331:1630-1641.
2. Levine M, Gent M, Hirsh J, Leclerc J, Anderson D, Weitz J, Ginsberg J, Turpie AG, Demers C, Kovacs M, Geerts W, Kassis J, Desjardins L, Cusson J, Cruickshank M, Powers P, Brien W, Haley S, Willan A: A comparison of low-molecular weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med 1996;334:667-681.
3. Brandjes DP, Heijboer H, Buller HR, de Rijk M, Jagt TH, ten Cate JW: Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal-vein thrombosis. N Engl J Med 1992;327:1485-1489.
4. Koopman MM, Prandoni P, Piovella F, Ockelford PA, Brandjes DP, van der Meer J, Gallus AS, Simonneau G, Chesterman CH, Prins MH: Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The TASMAN Study Group. N Engl J Med 1996;334:682-687.
5. Wells PS, Kovacs MJ, Bormanis J, Forgie MA, Goudie D, Morrow B, Kovacs J: Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low-molecular-weight heparin. Arch Intern Med 1998;158:1809-1812.
6. Kovacs MJ, Cruickshank M, Wells PS, Kim H, Chin-Yee I, Morrow B, Boyle E, Kovacs J: Randomized assessment of a warfarin nomogram for initial oral anticoagulation after venous thromboembolic disease. Haemostasis 1998;28:62-69.
7. Fennerty A, Bolben J, Thomas P, Backhouse G, Bentley DP, Campbell IA, Routledge PA: Flexible induction dose regimen for warfarin and prediction of maintenance dose. Br Med J Clin (Res Ed) 1984;288:1268-1270.
8. Doecke CJ, Cosh DG, Gallus AS: Standardized initial warfarin treatment: Evaluation of initial treatment response and maintenance dose prediction by randomized trial, and risk factors for an excessive warfarin response. Aust NZ J Med 1991;21:319-324.
9. Harrison L, Johnston M, Massicotte MP, Crowther M, Moffat K, Hirst J: Comparison of 5-mg and 10-mg loading doses in initiation of warfarin therapy. Ann Intern Med 1997;126:133-136.
10. Crowther MA, Harrison L, Hirsh J: Warfarin: Less may be better. Ann Intern Med 1997;127:332-333.